With the cutting-edge platform technology, the Korean SME has been leading the molecular diagnostics market in Korea since 2013, based on PNA, Peptide Nucleic Acid. The company has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. PNA is an artificial DNA, or DNA/RNA analogue, which can be used to various applications and it has high potential to be applied as new therapeutics material, especially for oncology molecular diagnosis and mutation detection.